Savant Capital LLC Has $1.60 Million Holdings in CVS Health Co. (NYSE:CVS)

Savant Capital LLC lessened its position in shares of CVS Health Co. (NYSE:CVS) by 50.1% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 35,713 shares of the pharmacy operator’s stock after selling 35,923 shares during the quarter. Savant Capital LLC’s holdings in CVS Health were worth $1,603,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. MidAtlantic Capital Management Inc. acquired a new stake in CVS Health during the 3rd quarter valued at approximately $25,000. Livelsberger Financial Advisory acquired a new stake in CVS Health during the 3rd quarter valued at approximately $31,000. Legacy Investment Solutions LLC acquired a new stake in CVS Health during the 3rd quarter valued at approximately $31,000. Reston Wealth Management LLC acquired a new stake in CVS Health during the 3rd quarter valued at approximately $32,000. Finally, Ridgewood Investments LLC boosted its holdings in shares of CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 450 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have issued reports on CVS shares. Leerink Partners upgraded CVS Health from a “market perform” rating to an “outperform” rating and increased their price target for the stock from $55.00 to $75.00 in a report on Thursday. Deutsche Bank Aktiengesellschaft upgraded CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price target on the stock in a report on Tuesday, December 3rd. Wolfe Research increased their price target on CVS Health from 67.00 to 70.00 and gave the stock an “overweight” rating in a report on Tuesday. Royal Bank of Canada cut their price target on CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a report on Friday, November 15th. Finally, Truist Financial increased their price target on CVS Health from $60.00 to $76.00 and gave the stock a “buy” rating in a report on Thursday. Five investment analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company. According to data from MarketBeat, CVS Health has a consensus rating of “Moderate Buy” and a consensus price target of $70.28.

CVS Health Price Performance

Shares of NYSE:CVS opened at $66.35 on Friday. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The stock’s fifty day simple moving average is $50.71 and its two-hundred day simple moving average is $55.94. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $80.75. The stock has a market cap of $83.49 billion, a PE ratio of 16.84, a price-to-earnings-growth ratio of 0.60 and a beta of 0.61.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. As a group, analysts forecast that CVS Health Co. will post 5.14 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.01%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s dividend payout ratio is presently 72.68%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.